Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Sort descending Title Grant Number Initiative Program Official
Rosenbluth, Jennifer M.

University Of California, San Francisco
United States

In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer 4R01CA281361-04 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-04 PAR-21-329 (R01 Clinical Trial Optional) Rachel Altshuler, Ph.D.
Rosser, Charles J

Cedars-Sinai Medical Center
United States

A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology 5R01CA277810-03 Guillermo Marquez, Ph.D.
Buczynski, Matthew Wallace

Virginia Polytechnic Inst And St Univ
United States

Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy 5R01CA284075-03 Rachel Altshuler, Ph.D.
Velculescu, Victor E.

Johns Hopkins University
United States

DNA evaluation of fragments for early interception (DELFI) of Lung cancer 5U01CA271896-03 Guillermo Marquez, Ph.D.
Salami, Simpa Samuel

University Of Michigan At Ann Arbor
United States

Defining the Biological Arc of Grade Group 1 Prostate Cancer 5R37CA283857-03 Guillermo Marquez, Ph.D.
Gudas, Lorraine J

Weill Medical Coll Of Cornell Univ
United States

CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention 5R01CA270248-03 Anda Vlad, M.D., Ph.D.
Robertson, Sarah E

Dartmouth College
United States

Learning about the effectiveness of lung cancer screening in real-world target populations 4R00CA287059-03 Neeraj Saxena, Ph.D.
Nappi, Lucia

Provincial Health Services Authority
United States

Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. 5R37CA264798-03 PAR-19-264 (R01 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Badve, Sunil S.

Emory University
United States

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms 5R01CA281932-02 Wendy Wang, Ph.D., M.Sc.